menu
    • menu

    Company profile for Akeso

    NEW Drugs in Dev: 37
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.Since our establishment, the Company has established a comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including ta...
    Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.Since our establishment, the Company has established a comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including target validation, antibody drug discovery and development, process development, and GMP-compliant commercial-scale manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AkesoChina Flag
    Country
    Country
    China
    Address
    Address
    No. 6, Shennong Road, Torch Development Zone, Zhongshan City, Guangdong Provin...
    Telephone
    Telephone
    0760-8987 3998
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.akesobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akeso-bio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AkesoInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ivonescimab Gains Broad Backing in 2026 CSCO NSCLC Guidelines
    Ivonescimab Gains Broad Backing in 2026 CSCO NSCLC Guidelines

    28 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ivonescimab-receives-major-recommendations-across-multiple-therapies-in-the-2026-csco-nsclc-guideline-302755438.html

    PR NEWSWIRE
    28 Apr 2026
    Share Share
    Ivonescimab Shows QoL Benefits in Chemo-Free NSCLC: ELCC
    Ivonescimab Shows QoL Benefits in Chemo-Free NSCLC: ELCC

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ivonescimab-shows-quality-of-life-benefits-in-chemotherapy-free-first-line-nsclc-health-related-quality-of-life-data-from-the-harmoni-2-study-presented-at-elcc-2026-302729798.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    China Clears Akeso IL-4R?/ST2 Ph 2 for Respiratory, Autoimmune
    China Clears Akeso IL-4R?/ST2 Ph 2 for Respiratory, Autoimmune

    11 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akesos-il-4rst2-bispecific-antibody-cleared-for-seven-phase-ii-studies-in-china-spanning-respiratory-and-autoimmune-indications-302684870.html

    PR NEWSWIRE
    11 Feb 2026
    Share Share
    FDA Accepts BLA for Ivonescimab Combo in NSCLC Post-TKI Therapy
    FDA Accepts BLA for Ivonescimab Combo in NSCLC Post-TKI Therapy

    30 Jan 2026

    // PRESS RELEASE

    https://smmttx.com/news/press-releases/news-details/2026/Summit-Therapeutics-Announces-U-S--FDA-Acceptance-of-Biologics-License-Application-BLA-Seeking-Approval-for-Ivonescimab-in-Combination-with-Chemotherapy-in-Treatment-of-Patients-with-EGFRm-NSCLC-Post-TKI-Therapy/default.aspx

    PRESS RELEASE
    30 Jan 2026
    Share Share
    Akeso's Second Gumokimab NDA For Ankylosing Spondylitis Accepted
    Akeso's Second Gumokimab NDA For Ankylosing Spondylitis Accepted

    19 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akeso-announces-nmpa-acceptance-of-second-nda-for-gumokimab-il-17a-inhibitor-in-active-ankylosing-spondylitis-302664371.html

    PR NEWSWIRE
    19 Jan 2026
    Share Share
    Ivonescimab + Chemo Shows Efficacy in TNBC at ESMO IO 2025
    Ivonescimab + Chemo Shows Efficacy in TNBC at ESMO IO 2025

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/updated-efficacy-data-of-ivonescimab-combined-with-chemotherapy-as-first-line-treatment-for-tnbc-presented-at-esmo-io-2025-302638641.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search